Why the study?
Does treatment with all 3 classes of guideline-recommended medications improve survival in patients after stroke?
Does treatment with all 3 classes of guideline-recommended medications improve survival in patients after stroke?
Treatment with all three guideline-recommended medication classes post-stroke is associated with improved survival.
Answers are grounded in this paper and cite their sources.
Supports triple therapy post-stroke in observational data; leaves open causality and needs RCTs before practice change.
Treatment with all 3 classes of guideline-recommended medications within 90 days after discharge was associated with better survival. Ongoing efforts are required to ensure optimal pharmacological intervention for secondary prevention of stroke.
No takes yet. Share an insight, caveat, or question.
Kilkenny et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: